Maintaining a therapeutic level of PHT in the blood can be a challenge for several reasons. Hepatic enzymes metabolize PHT with different speed among people, under the influence of age, genetic factors,coexisting disorders and organ function. Some patients are very sensitive to small changes in bioavailability and even small increases in dose can cause large increases in blood concentrations, enhancing the severity of side effects and causing PHT toxicity